Delivery Order SPE2DB24D2010-SPE2DB24FZWX5
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact 10 mg/ml oral solution (300 ml). The $2,558.34 firm fixed price contract has a period of performance through November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact 10 mg/mL oral solution. The contract has a ceiling value of $9,153.90 and a period of performance through April 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles. The firm-fixed price delivery order has a ceiling value of $1,429.97 and an ultimate completion date of November 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Briviact (Brivaracetam) 10 mg/mL oral solution. The contract has a firm fixed price, a ceiling value of $2,677.22, and a performance period through May 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $5,969.46, is for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles. The contract does not have a set-aside designation and has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,133.39, is for the delivery of Briviact 10 mg/ml oral solution, a neurological medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a specialty pharmaceutical product, Briviact 10 mg/ml oral solution 300 ml. The contract has a ceiling value of $3,411.16 and a performance period through March 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,101.53, is for the supply of the pharmaceutical product Briviact 100 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 17, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Medical Supply Chain organization within the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles, with a total ceiling value of $4,658.23 and a performance period ending on May 27, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,709.29, is for the delivery of 4,567,958,222 units of the prescription medication Briviact 100 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...